1 / 47

CHAPTER 11: Haemodialysis Practices

CHAPTER 11: Haemodialysis Practices. Shahnaz Shah Firdaus Khan Tan Chwee Choon Rafidah Abdullah Norleen Bt Zulkarnain Sim. Source: 21 st MDTR Report 2013, NRR. Table 11.1.1: Vascular access on haemodialysis, 2004-2013.

harper-mckay
Télécharger la présentation

CHAPTER 11: Haemodialysis Practices

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CHAPTER 11:Haemodialysis Practices Shahnaz Shah Firdaus Khan Tan Chwee Choon Rafidah Abdullah Norleen Bt Zulkarnain Sim Source: 21st MDTR Report 2013, NRR

  2. Table 11.1.1: Vascular access on haemodialysis, 2004-2013 *AVF = arteriovenoous fistula, BBF = Brachiobasilic fistula, BCF = brachiocephalic fistula Source: 21st MDTR Report 2013, NRR

  3. Table 11.1.2: Difficulties report with vascular access, 2004-2013 Source: 21st MDTR Report 2013, NRR

  4. Table 11.1.3: Complications reported with vascular access, 2004-2013 Source: 21st MDTR Report 2013, NRR

  5. Table 11.2.1: Blood flow rates in HD centers, 2004-2013 Source: 21st MDTR Report 2013, NRR

  6. Figure 11.2.1: Blood flow rates in HD centers, 2004-2013 <150 ml/min 150-199 ml/min 200-249 ml/min 250-299 ml/min 300-349 ml/min >=350 ml/min 40 30 % 20 10 0 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Year Source: 21st MDTR Report 2013, NRR

  7. Table 11.2.2: Number of HD sessions per week, 2004-2013 Source: 21st MDTR Report 2013, NRR

  8. Table 11.2.3: Duration of HD, 2004-2013 Source: 21st MDTR Report 2013, NRR

  9. Table 11.2.4: Dialyser membrane types in HD centres, 2004-2013 Source: 21st MDTR Report 2013, NRR

  10. Figure 11.2.4: Dialyser membrane types in HD centres, 2004-2013 Modified Cellulose Regenerated Cellulose Hydrophobic/Hypdrophilic Hydrophilized copolymers 100 90 80 70 60 % 50 40 30 20 10 0 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Year Source: 21st MDTR Report 2013, NRR

  11. Table 11.2.5: Dialyser reuse frequency in HD centres, 2004-2013

  12. Table 11.2.6(a): Distribution of prescribed Kt/V, HD patients 2004-2013 Source: 21st MDTR Report 2013, NRR

  13. Figure 11.2.6(a): Cumulative distribution of prescribed Kt/V, HD patients 2004-2013 2005 2007 2009 2011 2013 1 .75 Cumulative distribution .5 .25 0 1 1.2 1.4 1.6 1.8 2 2.2 2.4 KT/V Source: 21st MDTR Report 2013, NRR

  14. Table 11.2.6(b): Distribution of delivered Kt/V, HD patients 2009-2013 *Variance = (prescribed KT/V – delivered KT/V)/ Prescribed KT/V Source: 21st MDTR Report 2013, NRR

  15. Figure 11.2.6(b): Cumulative distribution of delivered Kt/V, HD patients 2009-2013 2009 2010 2011 2012 2013 1 .75 Cumulative distribution .5 .25 0 .8 1 1.2 1.4 1.6 1.8 2 2.2 KT/V Source: 21st MDTR Report 2013, NRR

  16. Table 11.2.6(c): Distribution of URR, HD patients 2009-2013 Source: 21st MDTR Report 2013, NRR

  17. Figure 11.2.6 (c): Cumulative distribution of URR, HD patients 2009-2013 2009 2010 2011 2012 2013 1 .75 Cumulative distribution .5 .25 0 55 60 65 70 75 80 85 90 URR Source: 21st MDTR Report 2013, NRR

  18. Table 11.2.7(a): Variation in median blood flow rates in HD patients, HD centres, 2004-2013 Source: 21st MDTR Report 2013, NRR

  19. Figure 11.2.7 (a): Variation in median blood flow rates in HD patients among centres 2013 Median blood flow rate (lower quartile, upper quartile) 400 350 300 Blood flow rate, ml/min 250 200 150 100 0 50 100 150 200 250 300 350 400 450 500 550 600 Centre Source: 21st MDTR Report 2013, NRR

  20. Table 11.2.7 (b): Proportion of patients with blood flow rates ≥ 300 ml/min, HD centres 2004-2013 Source: 21st MDTR Report 2013, NRR

  21. Figure 11.2.7 (b): Variation in Proportion of patients with blood flow rates >= 300 ml/min among HD centres 2013 % with blood flow rate >=300 ml/min (lower 95% CI, upper 95% CI) 100 90 80 70 60 % patients 50 40 30 20 10 0 0 50 100 150 200 250 300 350 400 450 500 550 600 Centre Source: 21st MDTR Report 2013, NRR

  22. Table 11.2.7(c): Proportion of patients with 3 HD sessions per week, HD centres 2004-2013 Source: 21st MDTR Report 2013, NRR

  23. Figure 11.2.7(c): Variation in proportion of patients with 3 HD sessions per week among HD centres 2013 Source: 21st MDTR Report 2013, NRR

  24. Table 11.2.7(d): Median prescribed Kt/V in HD patients, HD centres 2004-2013 Source: 21st MDTR Report 2013, NRR

  25. Figure 11.2.7(d): Variation in median prescribed Kt/V in HD patients among HD centres 2013 Median prescribed KT/V (lower quartile, upper quartile) 3.5 3 2.5 KT/V 2 1.5 1 0 50 100 150 200 250 300 350 400 450 500 550 600 Centre Source: 21st MDTR Report 2013, NRR

  26. Table 11.2.7(e): Proportion of patients with prescribed Kt/V ≥ 1.3, 2004-2013 Source: 21st MDTR Report 2013, NRR

  27. Figure 11.2.7(e): Variation in proportion of patients with prescribed Kt/V ≥ 1.3 among HD centres 2013 % with prescribed KT/V >=1.3 (lower 95% CI, upper 95% CI) 100 90 80 70 60 % patients 50 40 30 20 10 0 0 50 100 150 200 250 300 350 400 450 500 550 600 Centre Source: 21st MDTR Report 2013, NRR

  28. Table 11.2.7(f): Median delivered Kt/V in HD patients, HD centres 2009-2013 Source: 21st MDTR Report 2013, NRR

  29. Figure 11.2.7(f): Variation in median delivered Kt/V in HD patients among HD centres 2013 Median delivered KT/V (lower quartile, upper quartile) 2.4 2.2 2 1.8 1.6 KT/V 1.4 1.2 1 .8 .6 0 30 60 90 120 150 180 210 240 270 300 330 360 390 420 Centre Source: 21st MDTR Report 2013, NRR

  30. Table 11.2.7(g): Proportion of patients with delivered Kt/V ≥ 1.2, HD centres 2009-2013 Source: 21st MDTR Report 2013, NRR

  31. Figure 11.2.7(g): Variation in proportion of patients with delivered Kt/V ≥ 1.2, HD centres 2013 % with delivered KT/V >=1.2 (lower 95% CI, upper 95% CI) 100 90 80 70 60 % patients 50 40 30 20 10 0 0 30 60 90 120 150 180 210 240 270 300 330 360 390 420 Centre Source: 21st MDTR Report 2013, NRR

  32. Table 11.2.7(h): Median URR among HD patients, HD centres 2009-2013 Source: 21st MDTR Report 2013, NRR

  33. Figure 11.2.7(h): Variation in median URR among HD patients, HD centres 2013 Median URR (lower quartile, upper quartile) 100 90 80 URR % 70 60 50 40 0 50 100 150 200 250 300 350 400 450 500 550 600 Centre Source: 21st MDTR Report 2013, NRR

  34. Table 11.2.7(i): Proportion of HD patients with URR ≥ 65%, HD centres 2009-2013 Source: 21st MDTR Report 2013, NRR

  35. Figure 11.2.7(i): Variation in proportion of patients with URR ≥ 65% among HD centres 2013 % with URR >=65% (lower 95% CI, upper 95% CI) 100 90 80 70 60 % patients 50 40 30 20 10 0 0 50 100 150 200 250 300 350 400 450 500 550 600 Centre Source: 21st MDTR Report 2013, NRR

  36. Table 11.3.1(a): Unadjusted technique survival by year of entry, 2004-2013 Source: 21st MDTR Report 2013, NRR

  37. Figure 11.3.1(a): Unadjusted technique survival by year of entry, 2004-2013 Source: 21st MDTR Report 2013, NRR

  38. Table 11.3.1(b): Unadjusted technique survival by year of entry (censored for death & transplant), 2004-2013 Source: 21st MDTR Report 2013, NRR

  39. Figure 11.3.1(b): Unadjusted technique survival by year of entry (censored for death & transplant), 2004-2013 Source: 21st MDTR Report 2013, NRR

  40. Table 11.3.2(a): Unadjusted technique survival by age, 2004-2013 Source: 21st MDTR Report 2013, NRR

  41. Figure 11.3.2(a): Unadjusted technique survival by age, 2004-2013 Source: 21st MDTR Report 2013, NRR

  42. Table 11.3.2(b): Unadjusted technique survival by age (censored for death & transplant), 2004-2013

  43. Figure 11.3.2(b): Unadjusted technique survival by age (censored for death & transplant), 2004-2013 Source: 21st MDTR Report 2013, NRR

  44. Table 11.3.3(a): Unadjusted technique survival by diabetes status, 2004-2013 Source: 21st MDTR Report 2013, NRR

  45. Figure 11.3.3(a): Unadjusted technique survival by diabetes status, 2004-2013 Kaplan-Meier survival estimates, by Diabetes 1.00 0.75 Non-diabetic Cumulative survival 0.50 Diabetic 0.25 0.00 0 12 24 36 48 60 72 84 96 108 120 Duration in months Source: 21st MDTR Report 2013, NRR

  46. Table 11.3.3(b): Unadjusted technique survival by diabetes status (censored for death & transplant), 2004-2013 Source: 21st MDTR Report 2013, NRR

  47. Figure 11.3.3(b): Unadjusted technique survival by diabetes status (censored for death & transplant), 2004-2013 Kaplan-Meier survival estimates, by Diabetes 1.00 Non-diabetic Diabetic 0.75 Cumulative survival 0.50 0.25 0.00 0 12 24 36 48 60 72 84 96 108 120 Duration in months Source: 21st MDTR Report 2013, NRR

More Related